Nervous System Part 2: Brain, Basal Ganglia & Parkinson's | BSCMLT

Added:

Brain Anatomy
Nervous System
Basal Ganglia
Motor Control
Putamen Role
Motor Timing
Parkinson's Disease
PD Causes
PD Treatment
Summary

Brain Anatomy

0:05
Playing Section
  • 1

    Embryological brain division into forebrain, midbrain, and hindbrain.

  • 2

    Detailed development of telencephalon into cerebral hemispheres at six weeks.

  • 3

    Overview of major brain regions like cerebrum, thalamus, and medulla oblongata.

Basic neuroanatomy, including the fundamental divisions of the Central Nervous System (CNS) and Peripheral Nervous System (PNS).
The structure and function of neurons, specifically focusing on synaptic transmission and action potentials.
An introduction to major neurotransmitters, particularly the inhibitory and excitatory roles of dopamine, GABA, and glutamate.
The general concept of motor pathways and how the cerebral cortex initiates and regulates voluntary movement.
The detailed physiology of the direct and indirect pathways (the accelerator and brake systems) within the basal ganglia loop.
Pharmacological interventions for Parkinson's disease, including the mechanisms of action of L-DOPA, carbidopa, and dopamine agonists.
The neuropathology and histopathology of neurodegenerative diseases, such as Lewy body formation in Parkinson's and caudate atrophy in Huntington's.
Clinical laboratory diagnostics and biomarker identification for central nervous system disorders, relevant to medical laboratory technology.
588 views18likes26:58@mlthealthyvlogsOriginal Release: 2021-09-23

The basal ganglia, located in the inner side of the cerebrum lateral to the thalamus, consist of five nuclei (caudate nucleus, putamen, globus pallidus, substantia nigra, and subthalamic nucleus) that play crucial roles in motor control, learning, and memory. The caudate nucleus is particularly involved in executing complex motor activities like writing and drawing, and lesions here can cause patients to forget recently written content. Parkinson's disease is a progressive degenerative disorder caused by dopamine destruction in the substantia nigra, treated with L-Dopa which crosses the blood-brain barrier and converts to dopamine. Huntington's disease is an inherited progressive disorder characterized by chorea and cognitive decline, primarily affecting the basal ganglia.